Multiple endocrine neoplasia type 1 (MEN1) is an endocrine tumor syndrome caused by heterozygous mutations in the MEN1 tumor suppressor gene. The MEN1 pancreas of the adolescent gene carrier frequently contain diffusely spread pre-neoplasias and microadenomas, progressing to macroscopic and potentially malignant pancreatic neuroendocrine tumors (P-NET), which represents the major death cause in MEN1. The unveiling of the molecular mechanism of P-NET which is not currently understood fully to allow the optimization of diagnostics and treatment. Glucagon-like peptide 1 (GLP-1) pathway is essential in islet regeneration, i.e. inhibition of β-cell apoptosis and enhancement of β-cell proliferation, yet involvement of GLP-1 in MEN1 related P-NET ...
Multiple Endocrine Neoplasia Type 1 (MEN1) is an autosomal dominant disorder characterized by the co...
Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder characterised by occurr...
Multiple Endocrine Neoplasia Type I syndrome (MEN1) is a rare hereditary tumoral disease characteriz...
Multiple endocrine neoplasia type 1 (MEN1) is an endocrine tumor syndrome caused by heterozygous mut...
Diabetes epidemic is underway. Beta cell dysfunction (BCF) and loss of beta cell mass (BCM) are know...
PURPOSE: Insulinomas are neuroendocrine tumours derived from pancreatic beta-cells. The glucagon-lik...
Multiple Endocrine Neoplasia Type I Syndrome (MEN 1) is a monogenic autosomal dominantly inherited c...
Imaging with radiolabeled exendin enables detection and characterization of glucagon-like peptide 1 ...
Inhibition of glucagon signaling causes hyperglucagonemia and pancreatic α cell hyperplasia in mice....
Pancreatic duct glands (PDGs) have been hypothesized to give rise to pancreatic intraepithelial neop...
Animal models with defective glucagon action show hyperplasia of islet α-cells, however, the regulat...
The function of the predisposition gene to multiple endocrine neoplasia type 1 (MEN1) syndrome remai...
Multiple endocrine neoplasia type 1 (MEN1) is an inherited cancer predisposition syndrome typified b...
In subjects with type 2 diabetes mellitus (T2DM), pancreatic β-cell mass decreases; however, it is u...
Animal models with defective glucagon action show hyperplasia of islet α-cells, however, the regulat...
Multiple Endocrine Neoplasia Type 1 (MEN1) is an autosomal dominant disorder characterized by the co...
Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder characterised by occurr...
Multiple Endocrine Neoplasia Type I syndrome (MEN1) is a rare hereditary tumoral disease characteriz...
Multiple endocrine neoplasia type 1 (MEN1) is an endocrine tumor syndrome caused by heterozygous mut...
Diabetes epidemic is underway. Beta cell dysfunction (BCF) and loss of beta cell mass (BCM) are know...
PURPOSE: Insulinomas are neuroendocrine tumours derived from pancreatic beta-cells. The glucagon-lik...
Multiple Endocrine Neoplasia Type I Syndrome (MEN 1) is a monogenic autosomal dominantly inherited c...
Imaging with radiolabeled exendin enables detection and characterization of glucagon-like peptide 1 ...
Inhibition of glucagon signaling causes hyperglucagonemia and pancreatic α cell hyperplasia in mice....
Pancreatic duct glands (PDGs) have been hypothesized to give rise to pancreatic intraepithelial neop...
Animal models with defective glucagon action show hyperplasia of islet α-cells, however, the regulat...
The function of the predisposition gene to multiple endocrine neoplasia type 1 (MEN1) syndrome remai...
Multiple endocrine neoplasia type 1 (MEN1) is an inherited cancer predisposition syndrome typified b...
In subjects with type 2 diabetes mellitus (T2DM), pancreatic β-cell mass decreases; however, it is u...
Animal models with defective glucagon action show hyperplasia of islet α-cells, however, the regulat...
Multiple Endocrine Neoplasia Type 1 (MEN1) is an autosomal dominant disorder characterized by the co...
Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder characterised by occurr...
Multiple Endocrine Neoplasia Type I syndrome (MEN1) is a rare hereditary tumoral disease characteriz...